AI-generated summary
The authors systematically reviewed 34 original studies on the vascular component of melasma, including laboratory, diagnostic, and therapeutic work. They report promising evidence for tranexamic acid and laser or light therapies, but state that more rigorous clinical trials are needed to validate their efficacy.
- Studies included
- 34
- Who or what was studied
- Patients with melasma, a common acquired hyperpigmentation disorder, and original research studies on vascularity in melasma or antivascular therapies for it
- Limits stated in the abstract
- The abstract states that more rigorous clinical trials are needed to validate efficacy, and the evidence base is described as promising rather than definitive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.